FIELD ORTHOPAEDICS RECIEVES US FDA CLEARANCE FOR EASS GRIPLASTYTM SYSTEMS - INCLUDING A SINGLE INCISION ALL SUTURE IMPLANT DESIGNED TO ADDRESS ADVANCED-STAGE THUMB CARPOMETACARPAL OSTEOARTHRITIS (CMC OA)
BRISBANE, AUSTRALIA - Field Orthopaedics Pty. Ltd., a leader in innovative hand surgery solutions, announces US FDA (Food and Drug Administration) clearance of its Extremity All Suture System (EASS) GriplastyTM Systems. The innovative GriplastyTM System - Base of Thumb will be launched in the USA at this year’s American Society for Surgery of the Hand (ASSH) annual meeting, being held from September 19 to 21, 2024 at the Minneapolis Convention Center in Minneapolis, MN.
The GriplastyTM System – Base of Thumb, part of the Extremity All Suture System, represents a significant advancement in Field Orthopaedics' hand implant portfolio. Designed to address the needs of patients suffering from a common form of peripheral arthritis (1,2), the GriplastyTM System offers a versatile and effective solution for hand surgeons.
"The GriplastyTM implant optimizes the suspension of the thumb to maintain length and support anatomical planes of movement. This represents an exciting opportunity for hand surgeons who are looking to advance the surgical treatment of hand osteoarthritis and improve patient outcomes" - Dr Marc Richard, Associate Professor of Orthopaedic Surgery, Duke University.
Key features of the GriplastyTM System – Base of Thumb include:
• Single incision deployment using either dorsal or volar surgical approach
• 'V-Sling' implant design for broad surface area of multi-axis support
• Precise bi-cortical anchor deployment through a guidance system
• Compatibility with trapeziectomy and tendon transfer procedures
Symptomatic Thumb CMC OA occurs in up to 15% of the population aged 30 years or older, increasing to an estimated 33% of postmenopausal women (1). The GriplastyTM System's versatility ensures a treatment option for a wide range of patients. - catering to the significant market need.
Patryk Kania, CEO and Managing Director of Field Orthopaedics Pty Ltd, states, "We're thrilled to bring the GriplastyTM System to market. Our team has worked tirelessly over the past 12 months to make this surgical solution a reality. It embodies our commitment to innovation in hand surgery and our mission to improve patient outcomes in this under-served area of orthopaedics."
Learn more about the GriplastyTM System, visit: www.fieldorthopaedics.com/griplasty
About: Field Orthopaedics Pty. Ltd. is an Australian medical device company dedicated to leading innovation in complex hand fracture management, arthritis, and microsurgery, developing purpose-designed products for this unique market.
For media inquiries: investorrelations@fieldorthopaedics.com
Connect with Field Orthopaedics: https://www.linkedin.com/company/field-orthopaedics